SAB Biotherapeutics(SABS) - 2023 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (Exact name of Registrant as Specified in Its Charter) FORM 8-K (State or Other Jurisdiction of Incorporation) CURRENT REPORT Delaware 001-39871 85-3899721 (Commission File Number) (IRS Employer Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Identification No.) Date of Report (Date of earliest event reported): March 29, 2024 2100 East 54th Street North Sioux Falls, South Dakota 57104 (Address of Principal Executi ...